Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

Cited In for PubMed (Select 18458278)

1.

Chapter 1: Assessment of lipid status in adults with CKD.

[No authors listed]

Kidney Int Suppl (2011). 2013 Nov;3(3):268-270. No abstract available.

2.

Which lipid measurement should we monitor? An analysis of the LIPID study.

Glasziou PP, Irwig L, Kirby AC, Tonkin AM, Simes RJ.

BMJ Open. 2014 Feb 21;4(2):e003512. doi: 10.1136/bmjopen-2013-003512.

3.

Monitoring in clinical biochemistry.

Doust J, Glasziou P.

Clin Biochem Rev. 2013 Aug;34(2):85-92. Review.

4.

Journey in guidelines for lipid management: From adult treatment panel (ATP)-I to ATP-III and what to expect in ATP-IV.

Talwalkar PG, Sreenivas CG, Gulati A, Baxi H.

Indian J Endocrinol Metab. 2013 Jul;17(4):628-35. doi: 10.4103/2230-8210.113753.

5.

A pilot study identifying statin nonadherence with visit-to-visit variability of low-density lipoprotein cholesterol.

Mann DM, Glazer NL, Winter M, Paasche-Orlow MK, Muntner P, Shimbo D, Adams WG, Kressin NR, Zhang Y, Choi H, Cabral H.

Am J Cardiol. 2013 May 15;111(10):1437-42. doi: 10.1016/j.amjcard.2013.01.297. Epub 2013 Feb 20.

6.

Monitoring drug therapy.

Buclin T, Gotta V, Fuchs A, Widmer N, Aronson J.

Br J Clin Pharmacol. 2012 Jun;73(6):917-23. doi: 10.1111/j.1365-2125.2012.04237.x.

7.

The basis for monitoring strategies in clinical guidelines: a case study of prostate-specific antigen for monitoring in prostate cancer.

Dinnes J, Hewison J, Altman DG, Deeks JJ.

CMAJ. 2012 Feb 7;184(2):169-77. doi: 10.1503/cmaj.110600. Epub 2011 Dec 12.

8.

Improved blood tests for cancer screening: general or specific?

Cree IA.

BMC Cancer. 2011 Nov 30;11:499. doi: 10.1186/1471-2407-11-499.

9.

Fasting might not be necessary before lipid screening: a nationally representative cross-sectional study.

Steiner MJ, Skinner AC, Perrin EM.

Pediatrics. 2011 Sep;128(3):463-70. doi: 10.1542/peds.2011-0844. Epub 2011 Aug 1.

10.
11.

Development and validation of decision rules to guide frequency of monitoring CD4 cell count in HIV-1 infection before starting antiretroviral therapy.

Buclin T, Telenti A, Perera R, Csajka C, Furrer H, Aronson JK, Glasziou PP.

PLoS One. 2011 Apr 8;6(4):e18578. doi: 10.1371/journal.pone.0018578.

12.

The rise of cholesterol testing: how much is unnecessary.

Doll H, Shine B, Kay J, James T, Glasziou P.

Br J Gen Pract. 2011 Feb;61(583):e81-8. doi: 10.3399/bjgp11X556245.

13.

Variation in the net benefit of aggressive cardiovascular risk factor control across the US population of patients with diabetes mellitus.

Timbie JW, Hayward RA, Vijan S.

Arch Intern Med. 2010 Jun 28;170(12):1037-44. doi: 10.1001/archinternmed.2010.150.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk